Skip to main content
Inflammatory Bowel Diseases logoLink to Inflammatory Bowel Diseases
. 2021 Apr 20;27(8):1367. doi: 10.1093/ibd/izab078

Corrigendum to: Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease

PMCID: PMC8314096  PMID: 33991098

In the article titled “Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn’s Disease”, there was an error in the authors’ affiliation list. Co-author Silvio Danese’s affiliation should read: “IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center- IRCCS, Rozzano, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy” instead of “IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center, Milan, Italy”.

This error has now been corrected.


Articles from Inflammatory Bowel Diseases are provided here courtesy of Oxford University Press

RESOURCES